Verastem Oncology
VSTM
$3.96
Share price
-0.75%
Change (1 day)
288.24%
Change (1 year)
Categories
Verastem Oncology (VSTM) Fails to deliver data
Key failure to deliver metrics for Verastem Oncology :
- Last SEC data release: 2024-05-14
- Last 15 days FTD volume: $0.01 M
- Last 3 months FTD volume: $0.18 M
- Last year FTD volume: $6.12 M
Failures to deliver for Verastem Oncology (VSTM) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Verastem Oncology (VSTM) - since 2023
Volume in USD (price x number of shares), data since 2023Verastem Oncology (VSTM) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $0.5 M | -91.1% |
| 2023 | $5.62 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Pfizer PFE | $13.91 M | $0.31 B | 🇺🇸 USA |
 LabCorp LH | $0.01 M | $48.3 M | 🇺🇸 USA |
 GlaxoSmithKline GSK | $17.9 M | $24.11 M | 🇬🇧 UK |
 Curis CRIS | N/A | $0.94 M | 🇺🇸 USA |